ocrelizumab,rituximab,natalizumab,ofatumumab
novartis,roche,biogen
['ocrelizumab', 'ritux', 'natalizumab', 'ofatumumab', 'rituximab', 'love this']
great talk by at #aanam recommending last dose of ocrelizumab 6 weeks prior to conception and continuation with exclusive breastfeeding. ofatumumab can be taken immediately prior to conceptions. love this practical approach which emphasizes women s health. 
MS & NeuroIM Fellow @DCNSneuro / @MBCRMH | MS outcomes research @MSBase_Registry | MD, MSc (epi) ‘17 @UCalgaryMed | she/her 🏔🚲🛶